APR 21, 2017 1:16 PM PDT

Malaria Parasite Inspires New Bladder Cancer Drug

WRITTEN BY: Xuan Pham

The malaria parasite was the inspiration behind the newest drug for the treatment of bladder cancer. In particular, the drug derived from the malaria protein may be potent against some intractable forms of the disease.

Image credit: Pixabay.com

Bladder cancer doesn’t get as much attention as other cancers, like breast, kidney, or prostate cancer. However, bladder cancer accounts for about 5% of all new cancer cases in the U.S., and it is the fourth most prevalent cancer in men. In 2016, the American Cancer Society estimates nearly 77,000 new bladder cancer cases, which may claim more than 16,000 lives.

Though some types of bladder cancer have good prognoses, some types are resistant to standard chemotherapy treatments, such as cisplatin. This increases the risks for metastasis, which severely diminishes the survival outcomes.

To find new drug targets for bladder cancer, the research team, led by Mads Daugaard of the University of British Columbia, turned to the malaria parasite. They found that a protein derived from the parasite, called VAR2CSA, can deliver chemotherapy agents directly to the tumors. This protein targets the drug to based a sugar molecule that’s only present in cancer cells and the placenta.

"This is the first study where we put the concept of using malaria proteins for cancer therapy into a direct clinical context," said Daugaard, the study’s senior investigator. "There is a massive clinical need to find new treatments for bladder cancer and we saw an opportunity to target this disease with our new malaria drug."

In a mouse model of drug-resistant bladder cancer, the team found that the malaria protein correctly targeted the cancer drugs to the tumors. In addition, the tumors shrank in response to the the malaria drug combo. Animals treated with the malaria protein were alive for longer than the untreated control animals.

"No second line treatment option is available," said Daugaard. "We're very excited by these results because it shows that we are on our way to developing a completely new treatment option for lethal bladder cancer. It has the potential to have a tremendous impact on patient care."

The team’s next plan is scaling up the production of the VAR2CSA drug combo for clinical trials.

Additional source: University of British Columbia via EurekAlert!

 

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
AUG 13, 2021
Drug Discovery & Development
Breast Cancer Drug Reverses Deadly Blood Cancer in Mice
AUG 13, 2021
Breast Cancer Drug Reverses Deadly Blood Cancer in Mice
A drug currently used to treat advanced breast cancers may treat a rare type of leukemia known as myelofibrosis. The stu ...
AUG 19, 2021
Immunology
Immune Enzyme Kills Viruses but Makes Tumors Stronger
AUG 19, 2021
Immune Enzyme Kills Viruses but Makes Tumors Stronger
Robert Louis Stevenson’s 1886 novel Strange Case of Dr. Jekyll and Mr. Hyde describes a man who is a kind, respect ...
AUG 23, 2021
Cancer
A Safe and Effective Combination Therapy for Advanced Cancer
AUG 23, 2021
A Safe and Effective Combination Therapy for Advanced Cancer
Immunotherapies are emerging as a promising strategy for the treatment of late-stage cancers which currently have m ...
AUG 25, 2021
Cell & Molecular Biology
Sino Biological's Listing on the Shenzhen Stock Exchange
AUG 25, 2021
Sino Biological's Listing on the Shenzhen Stock Exchange
China, August 16, 2021 - Sino Biological, Inc. (“Sino Biological” or the “Company”), a biot ...
SEP 28, 2021
Immunology
Cell Therapy Scrubs Tumors, Spares Transplanted Organs
SEP 28, 2021
Cell Therapy Scrubs Tumors, Spares Transplanted Organs
Hepatitis B infections have created a ‘silent epidemic’—infected people don’t display any sympto ...
NOV 11, 2021
Clinical & Molecular DX
Cancer Pathologist Burnout? AI to the Rescue.
NOV 11, 2021
Cancer Pathologist Burnout? AI to the Rescue.
Diagnosing cancer is hard work. The challenging demands of their caseloads see diagnostic pathologists in many clinical ...
Loading Comments...